| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5924da6aa0bae257ffeae0538e3c9106 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13052 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
1991-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f5ae6dac341e78d4c42bee344dda29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a34a5ab92b2d3f158949379b3c19ac7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3070b76474deaa97ad226341b29136a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d01f39e26d9bf54015425713aa89bfeb |
| publicationDate |
1993-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0572401-A1 |
| titleOfInvention |
Viral particles having altered host range |
| abstract |
The present invention describes the incorporation of specific membrane-associated proteins into enveloped vector particles to provide an altered host range for these viruses. In a model system, the incorporation of vesicular stomatitis virus (VSV) G protein into retroviral vectors based on Moloney murine leukemia virus (MoMLV) is described. The invention describes methods for introducing genes into modified viruses, as well as the nucleic acid, proteins and cell lines associated with the modified virus. These gene introduction methods are used in various gene therapy methods. |
| priorityDate |
1991-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |